But if there is major news, such as progressing to Stage 2 of the clinical trial and people start to hear about ONCX it could move a lot. The share structure good. Low float. We've seen how it can move with volume.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.